US Stock MarketDetailed Quotes

ENDRA Life Sciences (NDRA)

Watchlist
  • 4.470
  • -0.120-2.61%
Close Jan 15 16:00 ET
  • 4.500
  • +0.030+0.67%
Pre 09:08 ET
5.21MMarket Cap-0.44P/E (TTM)

ENDRA Life Sciences (NDRA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-9.17%1.37M
-41.68%1.3M
-47.16%1.47M
2.82%10.82M
194.75%4.3M
-51.77%1.51M
-25.50%2.23M
-5.40%2.78M
-20.04%10.52M
-56.00%1.46M
Selling and administrative expenses
31.35%938.59K
-39.25%920.03K
-45.91%940.6K
38.24%7.63M
316.51%3.66M
-52.24%714.57K
-5.01%1.51M
12.34%1.74M
-16.45%5.52M
-46.76%878.43K
-Selling and marketing expense
-45.54%45.29K
-57.76%68.83K
-71.09%68.99K
-30.41%571.04K
-41.64%86.27K
-65.83%83.16K
-34.23%162.95K
31.41%238.66K
-42.58%820.55K
-54.76%147.83K
-General and administrative expense
41.48%893.31K
-37.02%851.2K
-41.91%871.61K
50.24%7.06M
388.99%3.57M
-49.60%631.41K
0.37%1.35M
9.80%1.5M
-9.23%4.7M
-44.79%730.6K
Research and development costs
-45.61%432.11K
-46.81%381.06K
-49.24%528.69K
-36.24%3.19M
10.12%637.96K
-51.35%794.44K
-48.84%716.37K
-25.14%1.04M
-23.66%5M
-65.17%579.35K
Operating profit
9.17%-1.37M
41.68%-1.3M
47.16%-1.47M
-2.82%-10.82M
-194.75%-4.3M
51.77%-1.51M
25.50%-2.23M
5.40%-2.78M
20.04%-10.52M
56.00%-1.46M
Net non-operating interest income expense
-7.32M
0
-7.32M
0
Total other finance cost
----
----
----
--7.32M
--0
--7.32M
----
----
----
----
Other net income (expense)
73.34%-225.26K
4,322.24%75.18K
8,843.44%432.95K
-250.02%-690.8K
8,513.15%147.74K
-3,093.96%-845.08K
-99.61%1.7K
241.63%4.84K
2,238.51%460.49K
-107.38%-1.76K
Gain on sale of security
70.65%-267.27K
--62.11K
--408.56K
---799.28K
--111.32K
---910.6K
----
----
----
----
Other non- operating income (expenses)
-35.88%42.02K
668.59%13.07K
403.82%24.39K
-76.44%108.48K
2,173.75%36.42K
132.15%65.53K
-99.61%1.7K
241.63%4.84K
2,238.51%460.49K
-107.38%-1.76K
Income before tax
32.20%-1.6M
45.01%-1.23M
62.66%-1.04M
-14.39%-11.51M
-184.27%-4.15M
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
23.67%-10.06M
55.63%-1.46M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
32.20%-1.6M
45.01%-1.23M
62.66%-1.04M
-14.39%-11.51M
-184.27%-4.15M
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
23.67%-10.06M
55.63%-1.46M
Net income continuous Operations
32.20%-1.6M
45.01%-1.23M
62.66%-1.04M
-14.39%-11.51M
-184.27%-4.15M
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
23.67%-10.06M
55.63%-1.46M
Minority interest income
Net income attributable to the parent company
32.20%-1.6M
45.01%-1.23M
62.66%-1.04M
-14.39%-11.51M
-184.27%-4.15M
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
23.67%-10.06M
55.63%-1.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
32.20%-1.6M
45.01%-1.23M
62.66%-1.04M
-14.39%-11.51M
-184.27%-4.15M
24.08%-2.35M
12.83%-2.23M
5.68%-2.78M
23.67%-10.06M
55.63%-1.46M
Basic earnings per share
77.99%-2.1
-2,037.50%-1.71
99.59%-1.86
97.94%-56.94
97.02%-7.7276
98.56%-9.54
99.99%-0.08
72.38%-449.58
65.33%-2.77K
85.60%-259.5948
Diluted earnings per share
77.99%-2.1
-2,037.50%-1.71
99.59%-1.86
97.94%-56.94
97.02%-7.7276
98.56%-9.54
99.99%-0.08
72.38%-449.58
65.33%-2.77K
85.60%-259.5948
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -9.17%1.37M-41.68%1.3M-47.16%1.47M2.82%10.82M194.75%4.3M-51.77%1.51M-25.50%2.23M-5.40%2.78M-20.04%10.52M-56.00%1.46M
Selling and administrative expenses 31.35%938.59K-39.25%920.03K-45.91%940.6K38.24%7.63M316.51%3.66M-52.24%714.57K-5.01%1.51M12.34%1.74M-16.45%5.52M-46.76%878.43K
-Selling and marketing expense -45.54%45.29K-57.76%68.83K-71.09%68.99K-30.41%571.04K-41.64%86.27K-65.83%83.16K-34.23%162.95K31.41%238.66K-42.58%820.55K-54.76%147.83K
-General and administrative expense 41.48%893.31K-37.02%851.2K-41.91%871.61K50.24%7.06M388.99%3.57M-49.60%631.41K0.37%1.35M9.80%1.5M-9.23%4.7M-44.79%730.6K
Research and development costs -45.61%432.11K-46.81%381.06K-49.24%528.69K-36.24%3.19M10.12%637.96K-51.35%794.44K-48.84%716.37K-25.14%1.04M-23.66%5M-65.17%579.35K
Operating profit 9.17%-1.37M41.68%-1.3M47.16%-1.47M-2.82%-10.82M-194.75%-4.3M51.77%-1.51M25.50%-2.23M5.40%-2.78M20.04%-10.52M56.00%-1.46M
Net non-operating interest income expense -7.32M0-7.32M0
Total other finance cost --------------7.32M--0--7.32M----------------
Other net income (expense) 73.34%-225.26K4,322.24%75.18K8,843.44%432.95K-250.02%-690.8K8,513.15%147.74K-3,093.96%-845.08K-99.61%1.7K241.63%4.84K2,238.51%460.49K-107.38%-1.76K
Gain on sale of security 70.65%-267.27K--62.11K--408.56K---799.28K--111.32K---910.6K----------------
Other non- operating income (expenses) -35.88%42.02K668.59%13.07K403.82%24.39K-76.44%108.48K2,173.75%36.42K132.15%65.53K-99.61%1.7K241.63%4.84K2,238.51%460.49K-107.38%-1.76K
Income before tax 32.20%-1.6M45.01%-1.23M62.66%-1.04M-14.39%-11.51M-184.27%-4.15M24.08%-2.35M12.83%-2.23M5.68%-2.78M23.67%-10.06M55.63%-1.46M
Income tax 0000000000
Net income 32.20%-1.6M45.01%-1.23M62.66%-1.04M-14.39%-11.51M-184.27%-4.15M24.08%-2.35M12.83%-2.23M5.68%-2.78M23.67%-10.06M55.63%-1.46M
Net income continuous Operations 32.20%-1.6M45.01%-1.23M62.66%-1.04M-14.39%-11.51M-184.27%-4.15M24.08%-2.35M12.83%-2.23M5.68%-2.78M23.67%-10.06M55.63%-1.46M
Minority interest income
Net income attributable to the parent company 32.20%-1.6M45.01%-1.23M62.66%-1.04M-14.39%-11.51M-184.27%-4.15M24.08%-2.35M12.83%-2.23M5.68%-2.78M23.67%-10.06M55.63%-1.46M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 32.20%-1.6M45.01%-1.23M62.66%-1.04M-14.39%-11.51M-184.27%-4.15M24.08%-2.35M12.83%-2.23M5.68%-2.78M23.67%-10.06M55.63%-1.46M
Basic earnings per share 77.99%-2.1-2,037.50%-1.7199.59%-1.8697.94%-56.9497.02%-7.727698.56%-9.5499.99%-0.0872.38%-449.5865.33%-2.77K85.60%-259.5948
Diluted earnings per share 77.99%-2.1-2,037.50%-1.7199.59%-1.8697.94%-56.9497.02%-7.727698.56%-9.5499.99%-0.0872.38%-449.5865.33%-2.77K85.60%-259.5948
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More